BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 17574688)

  • 1. Inhibition of hepatitis C virus p7 membrane channels in a liposome-based assay system.
    StGelais C; Tuthill TJ; Clarke DS; Rowlands DJ; Harris M; Griffin S
    Antiviral Res; 2007 Oct; 76(1):48-58. PubMed ID: 17574688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of hepatitis C virus p7 ion channel function and drug sensitivity identified in vitro.
    StGelais C; Foster TL; Verow M; Atkins E; Fishwick CW; Rowlands D; Harris M; Griffin S
    J Virol; 2009 Aug; 83(16):7970-81. PubMed ID: 19493992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A conserved basic loop in hepatitis C virus p7 protein is required for amantadine-sensitive ion channel activity in mammalian cells but is dispensable for localization to mitochondria.
    Griffin SDC; Harvey R; Clarke DS; Barclay WS; Harris M; Rowlands DJ
    J Gen Virol; 2004 Feb; 85(Pt 2):451-461. PubMed ID: 14769903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ion Channel Function and Cross-Species Determinants in Viral Assembly of Nonprimate Hepacivirus p7.
    Walter S; Bollenbach A; Doerrbecker J; Pfaender S; Brown RJP; Vieyres G; Scott C; Foster R; Kumar A; Zitzmann N; Griffin S; Penin F; Pietschmann T; Steinmann E
    J Virol; 2016 May; 90(10):5075-5089. PubMed ID: 26962224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotype-dependent sensitivity of hepatitis C virus to inhibitors of the p7 ion channel.
    Griffin S; Stgelais C; Owsianka AM; Patel AH; Rowlands D; Harris M
    Hepatology; 2008 Dec; 48(6):1779-90. PubMed ID: 18828153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance mutations define specific antiviral effects for inhibitors of the hepatitis C virus p7 ion channel.
    Foster TL; Verow M; Wozniak AL; Bentham MJ; Thompson J; Atkins E; Weinman SA; Fishwick C; Foster R; Harris M; Griffin S
    Hepatology; 2011 Jul; 54(1):79-90. PubMed ID: 21520195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular proton conductance of the hepatitis C virus p7 protein and its contribution to infectious virus production.
    Wozniak AL; Griffin S; Rowlands D; Harris M; Yi M; Lemon SM; Weinman SA
    PLoS Pathog; 2010 Sep; 6(9):e1001087. PubMed ID: 20824094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of a high-throughput screening assay for the hepatitis C virus p7 viroporin.
    Gervais C; Dô F; Cantin A; Kukolj G; White PW; Gauthier A; Vaillancourt FH
    J Biomol Screen; 2011 Mar; 16(3):363-9. PubMed ID: 21343600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell viability assay as a tool to study activity and inhibition of hepatitis C p7 channels.
    Breitinger U; Farag NS; Ali NKM; Ahmed M; El-Azizi MA; Breitinger HG
    J Gen Virol; 2021 Mar; 102(3):. PubMed ID: 33709903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C Virus p7 membrane protein quasispecies variability in chronically infected patients treated with interferon and ribavirin, with or without amantadine.
    Castelain S; Bonte D; Penin F; François C; Capron D; Dedeurwaerder S; Zawadzki P; Morel V; Wychowski C; Duverlie G
    J Med Virol; 2007 Feb; 79(2):144-54. PubMed ID: 17177298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patch-Clamp Study of Hepatitis C p7 Channels Reveals Genotype-Specific Sensitivity to Inhibitors.
    Breitinger U; Farag NS; Ali NKM; Breitinger HA
    Biophys J; 2016 Jun; 110(11):2419-2429. PubMed ID: 27276260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The p7 protein of hepatitis C virus forms an ion channel that is blocked by the antiviral drug, Amantadine.
    Griffin SD; Beales LP; Clarke DS; Worsfold O; Evans SD; Jaeger J; Harris MP; Rowlands DJ
    FEBS Lett; 2003 Jan; 535(1-3):34-8. PubMed ID: 12560074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amino acid variations in hepatitis C virus p7 and sensitivity to antiviral combination therapy with amantadine in chronic hepatitis C.
    Mihm U; Grigorian N; Welsch C; Herrmann E; Kronenberger B; Teuber G; von Wagner M; Hofmann WP; Albrecht M; Lengauer T; Zeuzem S; Sarrazin C
    Antivir Ther; 2006; 11(4):507-19. PubMed ID: 16856625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMR structure and ion channel activity of the p7 protein from hepatitis C virus.
    Montserret R; Saint N; Vanbelle C; Salvay AG; Simorre JP; Ebel C; Sapay N; Renisio JG; Böckmann A; Steinmann E; Pietschmann T; Dubuisson J; Chipot C; Penin F
    J Biol Chem; 2010 Oct; 285(41):31446-61. PubMed ID: 20667830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus p7: molecular function and importance in hepatitis C virus life cycle and potential antiviral target.
    Khaliq S; Jahan S; Hassan S
    Liver Int; 2011 May; 31(5):606-17. PubMed ID: 21457434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symmetric dimeric adamantanes for exploring the structure of two viroporins: influenza virus M2 and hepatitis C virus p7.
    Mandour YM; Breitinger U; Ma C; Wang J; Boeckler FM; Breitinger HG; Zlotos DP
    Drug Des Devel Ther; 2018; 12():1019-1031. PubMed ID: 29750015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational Study of HCV p7 Channel: Insight into a New Strategy for HCV Inhibitor Design.
    Ying B; Pang S; Yang J; Zhong Y; Wang J
    Interdiscip Sci; 2019 Jun; 11(2):292-299. PubMed ID: 30194627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational Docking Study of p7 Ion Channel from HCV Genotype 3 and Genotype 4 and Its Interaction with Natural Compounds.
    Mathew S; Fatima K; Fatmi MQ; Archunan G; Ilyas M; Begum N; Azhar E; Damanhouri G; Qadri I
    PLoS One; 2015; 10(6):e0126510. PubMed ID: 26030803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular design, synthesis and biological evaluation of cage compound-based inhibitors of hepatitis C virus p7 ion channels.
    Shiryaev VA; Radchenko EV; Palyulin VA; Zefirov NS; Bormotov NI; Serova OA; Shishkina LN; Baimuratov MR; Bormasheva KM; Gruzd YA; Ivleva EA; Leonova MV; Lukashenko AV; Osipov DV; Osyanin VA; Reznikov AN; Shadrikova VA; Sibiryakova AE; Tkachenko IM; Klimochkin YN
    Eur J Med Chem; 2018 Oct; 158():214-235. PubMed ID: 30218908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In depth analysis on the binding sites of adamantane derivatives in HCV (hepatitis C virus) p7 channel based on the NMR structure.
    Du QS; Wang SQ; Chen D; Meng JZ; Huang RB
    PLoS One; 2014; 9(4):e93613. PubMed ID: 24714586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.